EuropaBio and Smithers Rapra unveil the agenda for the European Forum for Industrial Biotechnology and Bioeconomy (EFIB) 2015. Taking place on 27-29 October 2015 at Square, Brussels, EFIB combines high-level discussions on business and policymaking and is the perfect setting for businesses looking to benefit from the next wave of activity in Europe.
While Industrial Biotechnology is currently estimated to be worth €28 billion in the EU, projections show that the EU market for IB products could develop to €40 billion by 2020, with significant potential to become the dominant technology of Europe’s future chemicals industry.
Key highlights include: Hear European policy keynote with Daniel Calleja Crespo from the European Commission. Learn about European investments and bioproducts for the future with CEOs of Corbion and Metsä Fibre. Understand the potential of the circular economy for biobased with Accenture, Ellen MacArthur Foundation, Interface and FrieslandCampina. Discover how Jaguar Landrover and Akzo Nobel are assessing and using biobased products. Join the discussions of funding and financing the bioeconomy with Waldemar Kütt, Head of Unit – BioBased products and processing at DG Research & Innovation. Insights from companies leading the way in Europe, with over 15 speakers confirmed, including Global BioEnergies, DuPont, DSM, Stora Enso and Bayer Material Sciences.
Il Bioeconomista is media partner of Efib. Our readers can book to attend the conference with an extra 15% discount. Valid in conjunction with the early bird rate until 7th August. Just enter code CD15ILBIO during the online registration to benefit from this discount.